March 10, 2022

FDA: Fresenius Kabi recalls Sodium Acetate Injection, USP, 400 mEq/100 mL

By: Judy Mathias

Editor's Note

The Food and Drug Administration on March 7 posted the recall by Fresenius Kabi USA (Lake Zurich, Illinois) of seven lots of its Sodium Acetate Injection, USP, 400 mEq/100 mL

The recall was initiated because of the presence of particulate matter found in reserve and/or stability sample vials.

The lot (Batch) numbers are: 6124193, 6124196, 6124226, 6124532, 6125333, 6125678, and 6126846. These lots were distributed between September 2020 and November 2021.

To date, no adverse event reports have been received for these recalled lots.


Join our community

Learn More
Video Spotlight
Live chat by BoldChat